Stay updated on Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T18:29:35.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added site revision indicator 'Revision: v3.4.2' and removed the prior 'lapse in government funding' notice and the 'Revision: v3.4.1' notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:23:11.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and NIH Clinical Center operations, and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:34:43.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page received minor UI/label updates: a 'Show glossary' option was added, the update-history line now reads 'Last Update Submitted that Met QC Criteria' with capitalization tweaks, 'No FEAR Act Data' was standardized to 'No FEAR Act data', and the revision tag was changed to 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T03:24:15.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:00:28.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page footer removes the HHS Vulnerability Disclosure link and adds a new revision note, Revision: v3.3.3 (replacing the previous v3.3.2).
    Difference
    0.1%
    Check dated 2025-12-23T09:17:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Nasopharyngeal Carcinoma Clinical Trial page.